[go: up one dir, main page]

TR200102786T2 - Auxiliary method to cessation. - Google Patents

Auxiliary method to cessation.

Info

Publication number
TR200102786T2
TR200102786T2 TR2001/02786T TR200102786T TR200102786T2 TR 200102786 T2 TR200102786 T2 TR 200102786T2 TR 2001/02786 T TR2001/02786 T TR 2001/02786T TR 200102786 T TR200102786 T TR 200102786T TR 200102786 T2 TR200102786 T2 TR 200102786T2
Authority
TR
Turkey
Prior art keywords
cessation
auxiliary method
hydrates
methyl
independently
Prior art date
Application number
TR2001/02786T
Other languages
Turkish (tr)
Inventor
Carl Mendel M.
Graham Stephan
Rotherham Neil
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of TR200102786T2 publication Critical patent/TR200102786T2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bu bulus sigaryi birakmayi saglayan bir yöntem olup, özelligi formül i'e uygun bilesikten yada bunun farmasötik açidan kabul edilebilir tuzlarindan veya hidratlarindan terapötik açidan etkili bir miktarinin verilmesini içermesidir, burada R1, ve R2 birbirinden bagimsiz olarak H veya metildir.This invention is a method of quitting smoking, characterized in that it comprises administering a therapeutically effective amount of the compound according to formula I or its pharmaceutically acceptable salts or hydrates, wherein R1 and R2 are independently H or methyl.

TR2001/02786T 1999-01-20 2000-01-19 Auxiliary method to cessation. TR200102786T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11668199P 1999-01-20 1999-01-20
US14824699P 1999-08-11 1999-08-11

Publications (1)

Publication Number Publication Date
TR200102786T2 true TR200102786T2 (en) 2002-05-21

Family

ID=26814491

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2001/02786T TR200102786T2 (en) 1999-01-20 2000-01-19 Auxiliary method to cessation.
TR2001/02999T TR200102999T2 (en) 1999-01-20 2000-01-19 Stop smoking

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2001/02999T TR200102999T2 (en) 1999-01-20 2000-01-19 Stop smoking

Country Status (19)

Country Link
EP (1) EP1150672A1 (en)
JP (1) JP2002535273A (en)
KR (1) KR20010111254A (en)
CN (1) CN1355696A (en)
AU (1) AU2730800A (en)
BG (1) BG105820A (en)
BR (1) BR0007633A (en)
CA (1) CA2359564A1 (en)
CZ (1) CZ20012662A3 (en)
HU (1) HUP0105431A3 (en)
ID (1) ID30432A (en)
IL (1) IL144390A0 (en)
MX (1) MXPA01007388A (en)
NO (1) NO20013575L (en)
NZ (1) NZ513638A (en)
PL (1) PL349002A1 (en)
SK (1) SK10312001A3 (en)
TR (2) TR200102786T2 (en)
WO (1) WO2000043002A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200102646T2 (en) * 1999-03-19 2002-08-21 Knoll Gmbh Treating eating disorders.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver

Also Published As

Publication number Publication date
BG105820A (en) 2002-06-28
CA2359564A1 (en) 2000-07-27
JP2002535273A (en) 2002-10-22
SK10312001A3 (en) 2002-03-05
MXPA01007388A (en) 2002-07-22
ID30432A (en) 2001-12-06
HUP0105431A3 (en) 2003-05-28
NO20013575L (en) 2001-09-11
EP1150672A1 (en) 2001-11-07
IL144390A0 (en) 2002-05-23
WO2000043002A1 (en) 2000-07-27
BR0007633A (en) 2002-01-02
TR200102999T2 (en) 2002-04-22
PL349002A1 (en) 2002-06-17
AU2730800A (en) 2000-08-07
CZ20012662A3 (en) 2002-08-14
NO20013575D0 (en) 2001-07-19
CN1355696A (en) 2002-06-26
NZ513638A (en) 2001-09-28
KR20010111254A (en) 2001-12-17
HUP0105431A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
BG106585A (en) Kinase inhibitors as therapeutic agents
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
ATE440603T1 (en) 8-HYDROXYQUINOLINE DERIVATIVES
ATE297203T1 (en) ANTITHRBOTIC AGENTS
BG106586A (en) Pyrazolopyramidines as therapeutic agents
DE69720773D1 (en) OXYGEN OR SULFUR CONTAINING 5-PIECE HETEROAROMATIS DERIVATIVE AS FACTOR Xa HEMMER
LU90856I2 (en) Uprima - apomorphine hydrochloride and its pharmaceutically acceptable derivatives
DE60107449D1 (en) SUBSTITUTED AMINOPROPOXYARYL DERIVATIVES AS LXR AGONISTS
UY26512A1 (en) NON-PEPTIDIC INHIBITORS OF THE VLA-DEPENDENT CELLULAR UNION - 4 USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES
AP2002002637A0 (en) Novel piperazine
TR200100432T2 (en) Hepatitis C inhibitor tri-peptides
AU1676200A (en) Polyhydroxylated heterocyclic derivatives as anti-coagulants
DE69919397D1 (en) Thrombin Inhibitors
NZ514453A (en) Novel sulfonamide compounds and uses thereof
MXPA02003977A (en) INHIBITORS OF agr;L.
IL133627A0 (en) Antithrombotic agents
TR200101120T2 (en) Serine protease inhibitor
YU73802A (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
EA199900591A1 (en) NITROGEN-CONTAINING HETEROAROMATIC COMPOUNDS AS INHIBITOR FACTOR XA
UY25679A1 (en) QUINOLIN-2-ONA DERIVATIVES FARNESIL PROTEIN TRANSFER INHIBITORS USEFUL AS AGENTS AGAINST CANCER
EA199800141A1 (en) HETEROCYCLIC COMPOUNDS
BG104740A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
TR200403436T2 (en) Crystalline 1-methylcarbapenem derivatives.
BG104447A (en) Biphenylamidine derivatives
DK1056754T3 (en) Phosphate derivatives of diaryl-1,3,4-oxadiazolone